Published by Benjamin Chiou on 5th November 2025
(Sharecast News) - Danish pharma giant Novo Nordisk has narrowed and lowered its guidance range for sales growth this year as heightened competition from cheaper weight-loss treatments continues to dampen the outlook for its breakthrough Ozempic and Wegovy drugs.
URL: http://www.digitallook.com/dl/news/story/35473268/...